iCRT 14 ( iCRT14; iCRT-14; iCRT 14; Wnt inhibitor )

Catalog No. M18982 CAS No. 677331-12-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

iCRT 14
Note

Research use only, not for human use.
Brief Description

iCRT 14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT)(IC50= 40.3 nM in assays of Wnt pathway activity).
Description

iCRT14 is a potent inhibitor of β-catenin-responsive transcription (CRT) that inhibits Wnt signaling in a reporter assay in vitro (IC50 = 40.3 nM). It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53.51 μM).
Synonyms

iCRT14; iCRT-14; iCRT 14; Wnt inhibitor
Pathway

Others
Target

Other Targets
Recptor

Wnt
Research Area

Cancer
Indication

——

CAS Number

677331-12-3
Formula Weight

375.44
Molecular Formula

C21H17N3O2S
Purity

98%
Solubility

DMSO : ≥ 29 mg/mL; 77.24 mM
SMILES

O=C4S\C(=C/c2cc(C)n(c1cccnc1)c2C)C(=O)N4c3ccccc3
Chemical Name

5-[[2,5-dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedione

1.Gonsalves FC, et al. Proc Natl Acad Sci USA. 2011 Apr 12;108(15):5954-63.

Calculator

molnova catalog